Adial Pharmaceuticals (ADIL) Assets (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted Assets of $5.2 million for Q1 2026, down 21.67% sequentially from $6.7 million in Q4 2025, and up 51.47% YoY from $3.5 million in Q1 2025.
Adial Pharmaceuticals (ADIL) Assets (2017 - 2026) Analysis & Trends
Adial Pharmaceuticals has reported Assets for 10 years, with the latest figure at $5.2 million in Q1 2026.
- Quarterly Assets rose 51.47% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 51.47% YoY) and the FY2025 annual result came in at $6.7 million, up 32.3% from the prior year.
- Assets slipped to $5.2 million in Q1 2026 per ADIL's latest filing, from $6.7 million in the prior quarter.
- Over five years, Assets peaked at $14.0 million in Q1 2022 and troughed at $2.9 million in Q3 2023.
- A 5-year average of $6.2 million and a median of $5.7 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets tumbled 72.06% in 2023, then surged 134.1% in 2024.
- Over 5 years, Assets stood at $5.7 million in 2022, then fell by 17.38% to $4.7 million in 2023, then advanced by 6.49% to $5.0 million in 2024, then jumped by 32.3% to $6.7 million in 2025, then fell by 21.67% to $5.2 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $5.2 million, $6.7 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Adial Pharmaceuticals | 28.42 Mn | 28.42 Mn | - | 29.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 6.67 Mn |
| Sep 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 5.04 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 4.95 Mn |
| Mar 31, 2024 | 6.68 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | 7.74 Mn |
| Jun 30, 2022 | 10.92 Mn |
| Mar 31, 2022 | 13.96 Mn |
| Dec 31, 2021 | 7.47 Mn |
| Sep 30, 2021 | 10.45 Mn |
| Jun 30, 2021 | 8.06 Mn |